Huawei Launches Global Education and Healthcare Partner Alliance to Unleash Value in Industry Ecosystem
Education and healthcare are greatly impacted by the rapid development of AI technologies and applications. Ernest Zhang, President of Partner Development and Commercial & Distribution Business Dept in Huawei Enterprise Sales Dept, stated that Huawei is committed to fully supporting its partners with enhanced capabilities, collaborative innovation, and a superior partnership experience. The goal is to ensure that more partners thrive through the cooperation, jointly serve the hundreds of thousands of education and healthcare customers worldwide, and build a more beautiful future for these industries in the age of AI.
Li Junfeng, Vice President of Huawei and CEO of Global Public Sector BU, stated out that the education and healthcare sectors are at the forefront of the global digital and intelligent transformation. Huawei is eager to work with partners to build a friendly, win-win, and sustainable global partner ecosystem. They will do this by creating joint solutions, nurturing industry ecosystems, setting benchmarks, and innovating cooperation models.
Peter Zhou, Vice President of Huawei and President of the Data Storage Product Line, stated that the healthcare industry's vast accumulation of high-quality data is key to leading AI implementation in the sector. He then proposed four initiatives: promoting standardized healthcare data and management, building shared intelligent diagnostic and treatment data infrastructure across departments and multiple hospital campuses, facilitating the tool-based and standardized development of data and model engineering, and accelerating the creation and adoption of sound AI diagnostic and treatment business models to foster a positive cycle.
Moving forward, Huawei plans to strengthen global collaborations, consistently innovating and applying new technologies in education and healthcare to address changing market needs. At the same time, Huawei will also commit to driving the high-quality development of the GEHPA, contributing to the sustainable growth of global education and healthcare.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Borneo Post
an hour ago
- Borneo Post
BRICS nations reshaping global perspectives through media and think tank cooperation
Xinhua News Agency president Fu Hua meets with important guests attending the BRICS Media and Think Tank Forum in Rio de Janeiro, Brazil on July 16, 2025. — Xinhua photo RIO DE JANEIRO (July 18): The BRICS Media and Think Tank Forum, convened this week in Rio de Janeiro, brought together voices from across the Global South to jointly reshape the narrative system and enhance the representation of developing countries in international affairs. The event served as a pivotal gathering for over 250 delegates from media outlets, think tanks, government institutions, and enterprises representing 36 countries, including BRICS member states, partner nations and regional organizations. Based on the broad consensus of the attendees, the forum delved into a range of critical topics under the theme 'BRICS United: Forging a New Chapter for the Global South.' Discussions focused on BRICS' role in leading the Global South's development, building a new digital future, and amplifying the voice of the Global South on the international stage. Building a shared digital future An initiative on artificial intelligence (AI) cooperation and development was unveiled at the forum, following extensive discussions among attendees on the roles and responsibilities of media and think tanks in advancing AI collaboration, shaping governance frameworks, and establishing technical standards for the Global South. Highlighting AI's significant momentum in global communication, industrial cooperation and knowledge sharing, the initiative noted that the BRICS media and think tanks, as a community of collective wisdom among emerging markets and developing countries, must ground their efforts in the realities of the Global South. It called for fostering a collaborative approach to R&D, standards and governance to ensure AI benefits are shared globally. Though AI has great potential to improve the quality of life worldwide, the enthusiasm for its benefits should not overshadow the potential risks posed by both intentional and unintentional use of its applications, said Edson Prestes e Silva Junior, a full professor at Institute of Informatics of the Federal University of Rio Grande do Sul, Brazil. 'Therefore, we need to strengthen collaboration between our countries and between the different segments of our societies, and that is exactly what we are doing right now,' he said at the forum. 'Only then will we be able to make the AI domain beneficial to our societies, now and in the future.' Shaping global governance In a world marked by geopolitical tensions, persistent inequalities and the urgent need for more representative global governance, the BRICS group has emerged as a key platform for engaging with rising economies, said Luis Rene Fernandez Tabio, a full professor at the International Economic Research Center at the University of Havana, Cuba. Echoing his view, Jose Juan Sanchez, chief of Brazil's financial and agricultural information provider CMA Group, said that despite their political and economic differences, BRICS countries share some strategic advantages that can be leveraged to advance the Global South's development and amplify its influence in global affairs. BRICS countries possess strong economic clout, abundant natural resources, development experience and financing capacity, positioning them as natural leaders in supporting the Global South, Sanchez noted. He added that by acting collectively and promoting cooperation, BRICS can reshape the global order to be more multipolar, inclusive and just. Ali Muhammad Ali, managing director of the News Agency of Nigeria, said BRICS is 'not just a grouping of emerging economies; we are a force to be reckoned with, and our influence is growing by the day.' 'For Nigeria, joining BRICS is a no-brainer. We are strategically positioned in Africa, and we are eager to reshape global governance, challenge Western-dominated institutions, and push for systemic reforms,' he added. Amplifying Global South's voice 'We are living through a transformative era — one in which global power dynamics are shifting, and the overlooked voices of the Global South are finally gaining clarity, strength and recognition,' said Datuk Wong Chun Wai, chairman of the Malaysian National News Agency (Bernama). BRICS offers an alternative voice — one that champions multipolarity, sovereignty and fairness in global governance, Wong noted. 'The rise of BRICS is not an isolated phenomenon. It is part of a broader awakening of the Global South, which is asserting itself as a central force in international affairs.' Mikhail Gusman, first deputy director-general of TASS, said the global media is grappling with unprecedented challenges: a deluge of disinformation, historical revisionism, and technological disruptions eroding the very foundations of truth. As a dynamic alliance embodying the voice of emerging economies and civilizational diversity, BRICS plays a decisive role in advancing the objective of strengthening a fair, multipolar and rules-based international order, Gusman added. The BRICS voice is 'loud and clear,' said Ali, the managing director of the News Agency of Nigeria, who noted that it represents a growing influence beyond the Global South and is shaping global governance, economic development, and international relations. 'We envision a prosperous Global South and a more just and equitable world,' he concluded. — Xinhua BRICS Media and Think Tank Forum Global South
Malay Mail
2 hours ago
- Malay Mail
Why seeing isn't believing anymore: What are deepfakes, and how to protect yourself from AI-generated scams
KUALA LUMPUR, July 18 — In today's digital world, seeing is no longer believing. With Artificial Intelligence (AI) becoming increasingly sophisticated, fake videos, audio clips and images that look and sound eerily real known as deepfakes are emerging as one of the biggest threats to truth and trust online. According to David Chak, co-founder and director of Arus Academy, which runs media literacy education programmes across Malaysia, deepfakes are no longer just a futuristic fear. What is a deepfake? Chak explained that deepfakes are highly realistic videos, images or audio recordings created using AI, specifically machine learning. He said these tools are trained to imitate a person's appearance, voice or mannerisms using existing footage or recordings so convincingly that they can trick even the most tech-savvy viewer. 'For example, with enough audio of Prime Minister Datuk Seri Anwar Ibrahim available online, AI can generate a deepfake video of him saying something completely fabricated whether that's a political statement or something as absurd as endorsing Oreo biscuits. 'These tools can be used for creative or entertainment purposes, but in the wrong hands, they are powerful tools of deception,' he told Malay Mail. Main types of AI-generated content Chak highlighted three main categories of AI-generated fake content: 1. Fake visuals (deepfake videos) Videos of someone appearing to do or say something they never did. One disturbing example is deepfake pornography, where someone's face is placed onto explicit content without their consent. 2. Fake audio AI can mimic someone's voice based on publicly available recordings. It is now possible to generate phone calls or voice notes that sound exactly like a politician, celebrity or even a loved one. 3. Combined audio and visual When visuals and audio are merged into a single synthetic video, the result can be indistinguishable from real footage. These are often disguised as breaking news or public announcements to manipulate emotions and spread misinformation. How to detect AI-generated content Also weighing in on the same matter, AI researcher with the Malaysian Research Accelerator for Technology and Innovation (MRANTI) Dr Afnizanfaizal Abdullah said there are a range of techniques to identify content that has been manipulated using AI. 1. Unnatural blinking and facial movement One common giveaway is how a person blinks. In real life, people blink around 15 to 20 times per minute with slight variation, but deepfakes may show unnatural blinking patterns or none at all. Changes in facial features from one video frame to the next may not align with natural human movement, making the footage appear subtly off. 2. Facial asymmetry and visual inconsistencies Minor imbalances in facial symmetry especially around the eyes and mouth can indicate manipulation. Deepfake videos often contain visual flaws, such as noticeable differences in image quality between the face and background caused by unusual compression. Edges around the altered parts of the face may look poorly blended or unnatural. 3. Lighting and shadow mismatches Lighting inconsistencies such as mismatched shadows, highlights or reflections can make the video appear unrealistic. 4. Frequency and noise anomalies Deepfakes can leave behind unusual frequency patterns in both the audio and video signals. Artificial clips often have different background noise or grain compared to authentic recordings, which can be detected through technical analysis. Existing detection tools struggling to keep up Although detection tools are improving, Afnizanfaizal said they are still struggling to keep pace with increasingly sophisticated AI. He cited research showing that detection accuracy can drop from 90 per cent to below 60 per cent after a video is forwarded or reshared several times. He then explained that commercial tools such as Sentinel, Reality Defender and DuckDuckGoose AI offer detection services using algorithms that analyse facial landmarks, motion consistency and spectral patterns. However, these are most effective when analysing original, high-resolution content. 'After three or four compression cycles, the digital fingerprints that help us detect deepfakes are often lost. That makes platforms like TikTok and WhatsApp especially challenging environments for verification,' he added. He also warned that synthetic audio and voice-cloning technologies are increasingly being exploited in Malaysian fraud cases, with the sophistication of these threats rising at an alarming pace. From a technical standpoint, the barriers to voice cloning have crumbled where modern AI voice synthesis can generate convincing clones using as little as 30 seconds of recorded speech. 'This accessibility has democratised voice cloning for criminal purposes, shifting it from the exclusive domain of state-level actors to tools now easily available to petty criminals,' he said. He added that criminal syndicates now use automated systems to extract voice samples from social media, video calls and phone recordings to quickly generate cloned voices. Some operations even maintain databases of voice profiles, specifically targeting high-value individuals or those with a strong social media presence. Looking ahead, he said that voice-based threats are likely to become even more advanced, incorporating emotional nuance, more accurate accent replication and potentially real-time language translation. Call for public awareness and regulations Technology expert and CEO of local IoT company Favoriot Sdn Bhd Dr Mazlan Abbas believes that while detection tools are important, the best defence lies in public awareness and stronger regulation. Despite the increasing prevalence of such content, he said Malaysia currently has no specific legislation addressing deepfakes. 'Enforcement agencies are still relying on existing laws such as the Communications and Multimedia Act to investigate malicious content or scams. 'But frankly, the technology is moving too fast for us to keep relying on old frameworks alone. We need regulations that are fit for this new digital era,' he said. When asked whether AI literacy and deepfake awareness should be formally introduced into the national education curriculum, he said it is crucial to start equipping the younger generation for the realities of an AI-driven future. 'We need to prepare our young people for this AI-driven world. Teaching deepfake awareness, digital ethics and AI literacy in schools will equip them with the critical thinking skills to question, verify and navigate the content they encounter online,' he said. However, he cautioned that education efforts should not overlook older generations, as they are among the most vulnerable targets for scammers using deepfakes. * Coming up in Part 2: Real voices, real faces — all faked. We break down how AI-generated scams are hitting Malaysians hard, from cloned boss calls to deepfake videos featuring politicians.
Malaysian Reserve
3 hours ago
- Malaysian Reserve
Facioscapulohumeral Muscular Dystrophy Market Gearing Up for Outstanding Expansion Across the 7MM During the Forecast Period (2025-2034)
According to DelveInsight's analysis, the market for facioscapulohumeral muscular dystrophy is anticipated to increase during the forecast period (2025–2034), owing to improved diagnosis, treatment advancements, aging demographics, increased awareness, the launch of emerging therapies, and healthcare spending globally. LAS VEGAS, July 17, 2025 /PRNewswire/ — Facioscapulohumeral muscular dystrophy (FSHD) often starts with muscle weakness in the face, shoulders, and upper arms, and gradually progresses to affect the abdominal muscles, legs, and pelvic area as the disease advances. Symptoms commonly emerge during childhood or adolescence, though they can begin at any stage of life, from infancy to old age. There is considerable variation in symptom onset and severity, even among relatives with the condition. Roughly 80% of individuals carrying the FSHD gene mutation experience symptoms, while the remaining 20% are asymptomatic, either showing no signs or only very mild symptoms that may go unnoticed until later in life. For FSHD1, children of an affected parent have a 50% likelihood of inheriting the disorder. In FSHD2, the inheritance risk depends on the genetic background of both parents, typically ranging from 25% to 50%. In 2024, the United States represented about 45% of all FSHD cases across the 7MM, with numbers projected to rise by 2034. Most US patients in 2024 scored between 7 and 10 on the RICCI scale, indicating moderate to severe levels of muscle dysfunction. Download the report to understand which factors are driving FSHD epidemiology trends @ Facioscapulohumeral Muscular Dystrophy Treatment Algorithm At present, there are no available therapies that can slow, halt, or reverse the progression of muscle weakness in facioscapulohumeral muscular dystrophy. While physical therapy can be beneficial in some cases, it is generally recommended that individuals engage in regular low-resistance and aerobic exercise. Collaborating with a physical therapist is important to create a personalized and safe exercise regimen. Some patients may benefit from surgical stabilization of the scapula to enhance their ability to raise their arms above shoulder level. Scapular fixation involves anchoring the shoulder blades to the ribs and may be performed on one or both sides. This is a complex procedure that should only be undertaken by skilled surgeons after thorough evaluation and discussion with both the surgeon and the neurologist. Additionally, medications such as NSAIDs, opioids, and antidepressants are commonly prescribed to manage FSHD-related pain. Current care practices are centered around managing complications and preserving physical function. Rehabilitation consultations are advised for individuals facing mobility or functional issues. However, there remains a significant unmet need for effective and affordable approved therapies, as existing supportive treatments are often costly and limited in efficacy. Learn more about the FSHD treatment @ New Treatment for Facioscapulohumeral Muscular Dystrophy There remains a significant unmet need in the treatment of FSHD, as current approaches primarily involve off-label therapies. Management strategies are largely aimed at alleviating symptoms and preserving physical function. Although FSHD is a progressive disorder with potentially serious long-term effects, treatment options are still limited to symptomatic care. Several investigational therapies are in development, including GYM329/RO7204239/RG6237 by Roche and Chugai Pharmaceutical, Delpacibart braxlosiran (del-brax) by Avidity Biosciences, EPI-321 by Epicrispr Biotechnologies, among others. Discover which therapies are expected to grab major FSHD market share @ Facioscapulohumeral Muscular Dystrophy Market Report GYM329 (also known as RO7204239 or RG6237) is an experimental anti-myostatin antibody aimed at enhancing skeletal muscle mass and growth. It has been specifically engineered as a 'recycling' and 'sweeping' antibody, meaning it may clear myostatin from the bloodstream more effectively than traditional antibodies. This targeted approach is expected to help address conditions marked by muscle wasting and reduced muscle strength. In November 2022, Roche began a Phase II clinical trial (NCT05548556) in patients with facioscapulohumeral muscular dystrophy, and according to the company, regulatory filing is anticipated after 2028. As per Chugai Pharmaceutical's Q1 2025 update, results from the ongoing MANOEUVRE Phase II study for FSHD are expected in 2025. With proof of concept established, Chugai plans to advance to Phase III trials, set to begin in 2026. Delpacibart braxlosiran (del-brax, formerly AOC 1020) is currently being assessed in the Phase I/II FORTITUDE trial (NCT06547216) in both adult and adolescent participants with FSHD. This study is focused on evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of intravenously administered del-brax. In June 2025, Avidity Biosciences announced that del-brax may qualify for an accelerated approval pathway in the U.S. for FSHD treatment. The company also launched the global Phase III FORWARD trial to serve as a confirmatory study for full regulatory approval. Additionally, Avidity reported positive topline results from the dose-escalation cohorts of the FORTITUDE trial, which will be shared at the 32nd Annual FSHD Society International Research Congress. EPI-321 is an investigational, one-time gene-silencing therapy targeting abnormal DUX4 expression. Administered systemically via a validated AAV vector, EPI-321 has shown strong preclinical results, including effective suppression of DUX4 and preservation of muscle tissue. It has received Fast Track, Orphan Drug, and Rare Pediatric Disease designations from the FDA. The company is preparing to launch a global Phase I/II trial in 2025. Discover more about drugs for FSHD in development @ Facioscapulohumeral Muscular Dystrophy Clinical Trials The anticipated launch of these emerging therapies for FSHD are poised to transform the market landscape in the coming years. As these cutting-edge therapies continue to mature and gain regulatory approval, they are expected to reshape the FSHD market landscape, offering new standards of care and unlocking opportunities for medical innovation and economic growth. DelveInsight estimates that the market size for FSHD is expected to grow at a significant CAGR by 2034. This growth is mainly driven by increased awareness, improved diagnostic techniques, and ongoing research into genetic therapies. Rising investment from pharmaceutical companies and the emergence of targeted therapies are expanding treatment options. Regulatory support for orphan diseases is also accelerating drug development. DelveInsight's latest published market report, titled as Facioscapulohumeral Muscular Dystrophy Market Insight, Epidemiology, and Market Forecast – 2034, will help you to discover which market leader is going to capture the largest market share. The report provides comprehensive insights into the FSHD country-specific treatment guidelines, patient pool analysis, and epidemiology forecast to help understand the key opportunities and assess the market's underlying potential. The FSHD market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into: Total Prevalent Cases of FSHD Total Diagnosed Prevalent Cases of FSHD Type-specific Diagnosed Prevalent Cases of FSHD Gender-specific Diagnosed Prevalent Cases of FSHD Age-specific Diagnosed Prevalent Cases of FSHD Severity-specific Diagnosed Prevalent Cases of FSHD Total Treated Cases of FSHD The report provides an edge while developing business strategies by understanding trends shaping and driving the 7MM FSHD market. Highlights include: 10-year Forecast 7MM Analysis Epidemiology-based Market Forecasting Historical and Forecasted Market Analysis upto 2034 Emerging Drug Market Uptake Peak Sales Analysis Key Cross Competition Analysis Industry Expert's Opinion Access and Reimbursement Download this FSHD market report to assess the epidemiology forecasts, understand the patient journeys, know KOLs' opinions about the upcoming treatment paradigms, and determine the factors contributing to the shift in the FSHD market. Also, stay abreast of the mitigating factors to improve your market position in the FSHD therapeutic space. Related Reports Facioscapulohumeral Muscular Dystrophy Pipeline Facioscapulohumeral Muscular Dystrophy Pipeline Insight – 2025 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key FSHD companies, including Fulcrum Therapeutics, Dyne Therapeutics, Hoffmann-La Roche, aTyr Pharma, Inc., Avidity Biosciences, Inc., among others. Facioscapulohumeral Muscular Dystrophy Epidemiology Forecast Facioscapulohumeral Muscular Dystrophy Epidemiology Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted FSHD epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Duchenne Muscular Dystrophy Market Duchenne Muscular Dystrophy Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key DMD companies, including Sarepta Therapeutics, PTC Therapeutics, Nippon Shinyaku, Santhera Pharmaceuticals, ReveraGen BioPharma, Taiho Pharmaceutical, FibroGen, Capricor, Daiichi Sankyo, Italfarmaco, Antisense Therapeutics, Solid Biosciences, among others. Spinal Muscular Atrophy Market Spinal Muscular Atrophy Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key SMA companies, including Scholar Rock, Biogen, Astellas Pharma, Alcyone Therapeutics, AndroScience Corporation, Hanugen Therapeutics, Voyager Therapeutics, Hoffmann-La Roche, Catalyst Pharmaceuticals, NMD Pharma, Biohaven Pharmaceuticals, CANbridge Pharmaceuticals Inc., Aurimed Pharma, Exicure, Amylon Therapeutics, Amniotics, among others. About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve. Contact Us Shruti Thakur info@ +14699457679 Logo: View original content:
